Renal cell carcinoma risk in type 2 von Hippel-Lindau disease correlates with defects in pVHL stability and
1Department of Molecular Cell Biology, Max Planck Institute of Biochemistry, Martinsried, Germany.
Abstract:
The von Hippel-Lindau (VHL) tumor suppressor protein is the substrate binding subunit of the CBC(VHL) E3 ubiquitin ligase complex. Mutations in the VHL gene cause a variety of tumors with complex genotype/phenotype correlations. Type 2A and type 2B VHL disease are characterized by a low or high risk of renal cell carcinoma, respectively. To investigate the molecular basis underlying the difference between disease types 2A and 2B, we performed a detailed biochemical analysis of the two most frequent type 2A mutations, Y98 H and Y112 H, in comparison to type 2B mutations in the same residues, Y98N and Y112N. While none of these mutations affected the assembly of CBC(VHL) complexes, the type 2A mutant proteins exhibited higher stabilities at physiological temperature. Moreover, the type 2A mutant proteins possessed higher binding affinities for the key cellular substrate, hypoxia-inducible transcription factor 1 (HIF-1alpha). Consistent with these results, type 2A but not type 2B mutant VHL proteins retained significant ubiquitin ligase activity towards HIF-1alpha in vitro. We propose that this residual ubiquitin ligase activity is sufficient to suppress renal cell carcinogenesis in vivo.
Insights
Mutations in the von Hippel-Lindau (VHL) gene impact cancer risk. Type 2A VHL disease mutants retain more activity against hypoxia-inducible transcription factor 1 (HIF-1alpha), suggesting a mechanism for lower renal cell carcinoma risk.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The von Hippel-Lindau (VHL) protein is crucial for regulating cellular processes as part of the CBC(VHL) E3 ubiquitin ligase complex.
- Mutations in the VHL gene are linked to diverse tumors, with distinct VHL disease types (2A and 2B) showing different risks for renal cell carcinoma.
Purpose of the Study:
- To elucidate the molecular differences between VHL disease types 2A and 2B.
- To investigate the impact of specific VHL mutations (Y98H, Y112H in type 2A; Y98N, Y112N in type 2B) on protein stability, substrate binding, and enzymatic activity.
Main Methods:
- Biochemical analysis of VHL mutant proteins.
- Assessment of CBC(VHL) complex assembly.
- Measurement of VHL mutant protein stability at physiological temperatures.
- Determination of binding affinities for hypoxia-inducible transcription factor 1 (HIF-1alpha).
- In vitro ubiquitin ligase activity assays using HIF-1alpha as a substrate.
Main Results:
- Type 2A VHL mutations (Y98H, Y112H) resulted in more stable mutant proteins compared to type 2B mutations (Y98N, Y112N).
- Type 2A mutants exhibited enhanced binding affinity for HIF-1alpha.
- Type 2A VHL mutants retained significant ubiquitin ligase activity towards HIF-1alpha in vitro, unlike type 2B mutants.
Conclusions:
- The increased stability and higher binding affinity of type 2A VHL mutants for HIF-1alpha contribute to their residual ubiquitin ligase activity.
- This retained enzymatic activity is proposed to be sufficient for suppressing renal cell carcinogenesis in type 2A VHL disease.
Related Concept Videos
Abnormal Proliferation
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Regulation of Angiogenesis and Blood Supply
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...


